MedTrace Logo

Evaluation of Dexketoprofen in Total Knee Arthroplasty

NCT04161690 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-11-13

No results posted yet for this study

Summary

Pain is a global public health issue and represents the most common reason for both physician consultation and hospital admissions. Dexketoprofen is a new NSAID treating acute postoperative pain. The purpose of this study is to evaluate the analgesic effect when it is given intravenously or as part of the local infiltration analgesia in patients under spinal anesthesia undergoing unilateral total knee arthroplasty.

Conditions

  • Postoperative Pain
  • Analgesia

Interventions

DRUG

Dexketoprofen Trometamol

intravenous dexketoprofen 50mg or intrathecal

DRUG

Ropivacaine Hydrochloride 7.5 MG/ML

Local Infiltration Analgesia

Sponsors & Collaborators

  • KAT General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-06
Primary Completion
2020-11-30
Completion
2021-11-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04161690 on ClinicalTrials.gov